Aclaris Therapeutics, Inc.
NASDAQ:ACRS
2.45 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -88.481 | -86.908 | -90.865 | -51.015 | -161.354 | -132.738 | -68.523 | -48.079 | -20.563 | -8.517 | -5.236 |
| Depreciation & Amortization
| 0.863 | 0.797 | 0.923 | 1.324 | 6.409 | 1.879 | 0.402 | 0.12 | 0.09 | 0.012 | 0.011 |
| Deferred Income Tax
| -0.367 | 0 | 0.752 | -0.182 | 44.292 | 0 | -1.837 | 0.216 | 0.289 | 0 | 0 |
| Stock Based Compensation
| 20.542 | 15.039 | 14.06 | 11.207 | 16.177 | 20.055 | 14.43 | 6.104 | 0.891 | 0.027 | 0 |
| Change In Working Capital
| 9.389 | -1.195 | -1.343 | -2.36 | -2.703 | 9.438 | 0.865 | 4.252 | -1.071 | 0.841 | 0.302 |
| Accounts Receivables
| 0.186 | 0.139 | 0.149 | 4.898 | -0.809 | -4.38 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0.605 | 0.102 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.473 | 0.368 | 3.655 | -5.219 | -3.16 | 6.964 | 4.564 | 1.81 | -0.359 | 0.819 | 0.303 |
| Other Working Capital
| 1.287 | -1.702 | -5.147 | -2.039 | 0.661 | 6.752 | -3.699 | 2.442 | -0.712 | 0.022 | -0.001 |
| Other Non Cash Items
| -20.271 | 4.7 | 24.339 | 2.393 | 0.734 | 0.555 | 10.67 | 2.784 | -0.005 | 0.001 | 0.003 |
| Operating Cash Flow
| -78.325 | -67.567 | -52.134 | -38.633 | -96.445 | -100.811 | -54.663 | -34.603 | -20.369 | -7.636 | -4.92 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -1.309 | -0.605 | -0.308 | -0.453 | -1.613 | -1.356 | -1.235 | -0.232 | -0.507 | -0.417 | 0 |
| Acquisitions Net
| -47.529 | -13.233 | 167.324 | -6.84 | 34.186 | -67.122 | -9.647 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -135.675 | -164.753 | -235.153 | -47.714 | -137.385 | -161.598 | -197.337 | -148.764 | -82.513 | -5.035 | -4.535 |
| Sales Maturities Of Investments
| 183.204 | 177.986 | 67.829 | 54.554 | 210.491 | 239.443 | 152.527 | 87.093 | 6.069 | 3.673 | 0 |
| Other Investing Activites
| 47.529 | 13.233 | -167.324 | 6.84 | 34.186 | 77.845 | -44.81 | -61.671 | -76.444 | -1.362 | -4.535 |
| Investing Cash Flow
| 46.22 | 12.628 | -167.632 | 6.387 | 105.679 | 9.367 | -55.692 | -61.903 | -76.951 | -1.779 | -4.535 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | -11.483 | -0.137 | -30.523 | -0.648 | -0.078 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 26.808 | 72.744 | 239.659 | 7.737 | 0.207 | 100.205 | 100.229 | 116.705 | 96.414 | 0 | 0 |
| Common Stock Repurchased
| -0.102 | -0.034 | -3.124 | 7.737 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 26.808 | 0.157 | -3.124 | 10.772 | -30.316 | 28.704 | 0.235 | 0.121 | 96.414 | 10.584 | 0 |
| Financing Cash Flow
| 26.706 | 72.867 | 225.052 | 18.372 | -30.316 | 128.261 | 100.386 | 116.826 | 96.414 | 10.584 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -5.399 | 17.928 | 5.286 | -13.874 | -21.082 | 36.817 | -9.969 | 20.32 | -0.906 | 1.169 | -9.455 |
| Cash At End Of Period
| 39.878 | 45.277 | 27.349 | 22.063 | 35.937 | 57.019 | 20.202 | 30.171 | 9.851 | 10.757 | 9.588 |